0 items USD 0.00Search
Your search for "gbi research frontier pharma chronic acute neuropathic pain gpcr nerve growth factor based" gave back 1549324 results.
Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021 Summary According to the recently...
Catalog:
Global Markets Direct
October 2021
Price: USD 3,500.00
The global Spinal Column Stimulation (SCS) Systems market size is expected to reach $ 3644 million by 2029, rising at a market growth of 7.8% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The Acute Pain Service provides care for patients requiring specialised techniques of analgesia, such as Patient Controlled Analgesia (PCA, Opioid...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Neuropathic Pain - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,500.00
The global Acute Pain Management Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
August 2020
Price: USD 2,000.00
Trigeminal Neuralgia - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
February 2018
Price: USD 2,000.00
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Ropivacaine Mesylate market size is expected to reach $ 1357.2 million by 2029, rising at a market growth of 6.1% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Ropivacaine Mesylate market size is projected to grow from US$ 851.1 million in 2022 to US$ 1334.7 million in 2029; it is expected to grow...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H1 2018 Summary...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
February 2020
Price: USD 2,000.00
